We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$7.62B
AUM Growth
+$501M
Cap. Flow
-$682M
Cap. Flow %
-8.96%
Top 10 Hldgs %
31.49%
Holding
3,289
New
550
Increased
1,163
Reduced
866
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 12.31%
2 Financials 6.67%
3 Industrials 4.87%
4 Consumer Discretionary 3.57%
5 Healthcare 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCYT icon
3251
Veracyte
VCYT
$4.52B
-70
Closed -$1.89K
VECO icon
3252
Veeco
VECO
$3.15B
-445
Closed -$9.04K
VIRC icon
3253
Virco
VIRC
$94.4M
-3
Closed -$24
VITL icon
3254
Vital Farms
VITL
$558M
-216
Closed -$8.32K
VOO icon
3255
Vanguard S&P 500 ETF
VOO
$968B
-1,177,459
Closed -$694M
VVX icon
3256
V2X
VVX
$2.62B
-1
Closed -$49
WATT icon
3257
Energous
WATT
$80.3M
-1
Closed -$7
WBA
3258
DELISTED
Walgreens Boots Alliance
WBA
-5,658
Closed -$65K
WEST icon
3259
Westrock Coffee
WEST
$741M
-62
Closed -$356
WGO icon
3260
Winnebago Industries
WGO
$870M
-226
Closed -$6.55K
WGS icon
3261
GeneDx Holdings
WGS
$1.75B
-58
Closed -$5.35K
WIX icon
3262
WIX.com
WIX
$2.15B
-248
Closed -$39.3K
WSR
3263
DELISTED
Whitestone REIT
WSR
-8
Closed -$100
XBIT icon
3264
XBiotech
XBIT
$69.2M
-17
Closed -$51
XFOR icon
3265
X4 Pharmaceuticals
XFOR
$363M
-64
Closed -$122
YMAB
3266
DELISTED
Y-mAbs Therapeutics
YMAB
-9
Closed -$41
ZETA icon
3267
Zeta Global
ZETA
$4.77B
-7
Closed -$109
ZURA icon
3268
Zura Bio
ZURA
$497M
-239
Closed -$251
FBLG icon
3269
FibroBiologics
FBLG
$4.33M
-10
Closed -$126
ANRO icon
3270
Alto Neuroscience
ANRO
$1.04B
-178
Closed -$392
MGX icon
3271
Metagenomi Therapeutics
MGX
$45.6M
-130
Closed -$193
PRKS icon
3272
United Parks & Resorts
PRKS
$2.11B
-182
Closed -$8.58K
BOLD
3273
Boundless Bio
BOLD
$57.8M
-24
Closed -$25
CTNM
3274
Contineum Therapeutics
CTNM
$526M
-33
Closed -$132
SKYE icon
3275
Skye Bioscience
SKYE
$22.9M
-12
Closed -$51

Similar funds

Clearstead Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Clearstead Advisors held 3,289 positions worth $7.62B, up 7% from $7.12B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clearstead Advisors withdrew a net $682M in Q3 2025, closing 207 positions and reducing 866 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $694M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Clearstead Advisors opened a new position in Invesco BulletShares 2033 Corporate Bond ETF worth $20.4M.

  • Clearstead Advisors's largest Q3 2025 buy was Invesco BulletShares 2033 Corporate Bond ETF: 949,887 shares worth $20.4M.
  • Clearstead Advisors added most to iShares Core MSCI Total International Stock ETF in Q3 2025, an estimated $22.8M increase.
  • Clearstead Advisors's biggest Q3 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $21.4M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $694M.
  • Clearstead Advisors's ten largest holdings make up 31% of its $7.62B portfolio in Q3 2025.
  • Clearstead Advisors opened 550 new positions and closed 207 in Q3 2025.
  • Clearstead Advisors's portfolio value rose 7% quarter-over-quarter to $7.62B.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.